Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.

Hong-Liang Li; Ai-Bing Wang; Yue Huang; De-Pei Liu; Chiming Wei; G Metville Williams; Chan-Na Zhang; Guang Liu; Yu-Qing Liu; De-Long Hao

doi:10.1016/j.freeradbiomed.2004.10.020

Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.

Identifier:nobleid.org/w1/20260515/4FD401BE

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/4FD401BE.svg?ark=w1%2F20260515%2F4FD401BE)](https://nobleid.org/work/w1/20260515/4FD401BE)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.

Identifier:nobleid.org/w1/20260515/4FD401BE

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/4FD401BE.svg?ark=w1%2F20260515%2F4FD401BE)](https://nobleid.org/work/w1/20260515/4FD401BE)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work